TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
60 Degrees Pharmaceuticals, Inc. ( (SXTP) ) has provided an update.
On October 8, 2025, 60 Degrees Pharmaceuticals, Inc. held its virtual 2025 Annual Stockholders Meeting, where various proposals were voted on by the shareholders. The meeting saw the election of five directors, approval of an amendment to increase shares in the 2022 Equity Incentive Plan, a reverse stock split, and the ratification of RBSM LLP as the accounting firm for 2025, all of which were approved.
The most recent analyst rating on (SXTP) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on 60 Degrees Pharmaceuticals, Inc. stock, see the SXTP Stock Forecast page.
Spark’s Take on SXTP Stock
According to Spark, TipRanks’ AI Analyst, SXTP is a Neutral.
SXTP’s overall stock score is primarily impacted by its weak financial performance, marked by declining revenues and persistent losses. Technical analysis provides some neutral signals, but valuation remains a concern due to negative profitability. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on SXTP stock, click here.
More about 60 Degrees Pharmaceuticals, Inc.
Average Trading Volume: 553,882
Technical Sentiment Signal: Sell
Current Market Cap: $6.36M
For an in-depth examination of SXTP stock, go to TipRanks’ Overview page.